Time and productivity loss associated with immunotherapy infusions for the treatment of melanoma in the United States: a survey of health care professionals and patients

Peer Review reports

Original Submission
9 Nov 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
4 Apr 2022	Reviewed	Reviewer Report
25 Jul 2022	Reviewed	Reviewer Report
12 Sep 2022	Author responded	Author comments - Raquel Aguiar-Ibáñez
Resubmission - Version 3
12 Sep 2022	Submitted	Manuscript version 3
19 Sep 2022	Author responded	Author comments - Raquel Aguiar-Ibáñez
Resubmission - Version 4
19 Sep 2022	Submitted	Manuscript version 4
15 Nov 2022	Author responded	Author comments - Raquel Aguiar-Ibáñez
Resubmission - Version 5
15 Nov 2022	Submitted	Manuscript version 5
Publishing
29 Nov 2022	Editorially accepted
9 Feb 2023	Article published	10.1186/s12913-022-08904-4

Back to article page